4.8 Article

Impact of peptide:HLA complex stability for the identification of SARS-CoV-2-specific CD8+T cells

Related references

Note: Only part of the references are listed.
Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study

Ivan A. Molodtsov et al.

Summary: In a prospective study involving 5340 individuals, the researchers found that both humoral and cellular responses to COVID-19 are closely related to the level of protection against infection. Individuals with both antibody and T-cell responses had the lowest incidence of COVID-19. Antibody response alone provided a significant level of protection, while T-cell response alone only offered intermediate protection.

CLINICAL INFECTIOUS DISEASES (2022)

Article Infectious Diseases

SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study

Li Guo et al.

Summary: This study investigated the durability and functionality of the humoral and T-cell response to the original SARS-CoV-2 strain and variants in recovered patients 12 months after infection. The results showed that neutralising antibodies and T-cell responses were retained 12 months after initial infection. However, the neutralising antibody responses to the D614G, beta, and delta variants were reduced compared to the original strain, while T-cell responses were cross-reactive to the beta variant. This suggests that cross-reactive T-cell responses may be particularly important in protecting against severe disease caused by variants, while neutralising antibody responses seem to diminish over time.

LANCET MICROBE (2022)

Article Multidisciplinary Sciences

Magnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunity

Martin J. Scurr et al.

Summary: Measurement of SARS-CoV-2-specific T cell responses in whole blood can predict the risk of infection. A low magnitude T cell response is associated with a higher risk of infection, while a high magnitude response significantly reduces the risk.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features

Anastasia Gangaev et al.

Summary: This study identified a range of SARS-CoV-2 CD8(+) T cell responses across COVID-19 patients, including an epitope from ORF1ab with immunodominant features. The specific CD8(+) T cell responses can still be detectable up to 5 months after recovery from critical and severe disease, converting from dysfunctional effector cells to functional memory cells during convalescence.

NATURE COMMUNICATIONS (2021)

Article Immunology

SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients

Sunil Kumar Saini et al.

Summary: This study experimentally evaluated MHC class I-binding peptides covering the complete SARS-CoV-2 genome, revealing significant CD8(+) T cell recognition of SARS-CoV-2 epitopes in patients with COVID-19, coupled with strong activation features in these T cells. Compared to healthy individuals, patients with severe disease displayed larger populations of SARS-CoV-2-specific T cells.

SCIENCE IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses

Anusha Nathan et al.

Summary: Through structure-based network analysis and assessment of HLA class I peptide stability, mutationally constrained CD8(+) T cell epitopes across the SARS-CoV-2 proteome have been identified. These epitopes have limited mutational frequencies in circulating variants and elicit CD8(+) T cell reactivity in convalescent individuals, but reduced recognition in recipients of mRNA-based vaccines.
Article Cell Biology

HLA class-I-peptide stability mediates CD8+ T cell immunodominance hierarchies and facilitates HLA-associated immune control of HIV

Clarety Kaseke et al.

Summary: The study found that immunodominant HIV epitopes increase surface stabilization of HLA class-I molecules compared to subdominant epitopes, and HLA class-I-peptide stability is strongly correlated with overall immunodominance hierarchies. Additionally, HLA alleles associated with HIV protection are preferentially stabilized by epitopes derived from topologically important viral regions.

CELL REPORTS (2021)

Article Microbiology

SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India

Sarah Cherian et al.

Summary: Genomic epidemiology and whole genome sequencing were used to investigate the transmission and evolution of the SARS-CoV-2 virus during the global pandemic. The study identified new variants B.1.617.1 and B.1.617.2 in India, responsible for the second wave of COVID-19 in Maharashtra, with B.1.617.2 designated as a VOC delta and B.1.617.1 as a variant of interest kappa. Monitoring of these and emerging variants in India is crucial for public health.

MICROORGANISMS (2021)

Article Oncology

Healthy Donors Harbor Memory T Cell Responses to RAS Neo-Antigens

Morten Orebo Holmstrom et al.

CANCERS (2020)

Article Biochemistry & Molecular Biology

The Immune Epitope Database (IEDB): 2018 update

Randi Vita et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Biochemical Research Methods

Gapped sequence alignment using artificial neural networks: application to the MHC class I system

Massimo Andreatta et al.

BIOINFORMATICS (2016)

Article Immunology

Human T cell responses to Japanese encephalitis virus in health and disease

Lance Turtle et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2016)

Article Biochemical Research Methods

Differential scanning fluorimetry based assessments of the thermal and kinetic stability of peptide-MHC complexes

Lance M. Hellman et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2016)

Article Multidisciplinary Sciences

Targeting of cancer neoantigens with donor-derived T cell receptor repertoires

Erlend Stronen et al.

SCIENCE (2016)

Review Immunology

Present Yourself! By MHC Class I and MHC Class II Molecules

Kenneth L. Rock et al.

TRENDS IN IMMUNOLOGY (2016)

Article Immunology

Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity

Mikkel Harndahl et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2012)

Article Biochemistry & Molecular Biology

Stability of peptide-HLA-I complexes and tapasin folding facilitation - tools to define immunogenic peptides

Linda Geironson et al.

FEBS LETTERS (2012)

Article Biochemical Research Methods

Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay

Mikkel Harndahl et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2011)

Article Multidisciplinary Sciences

One-Pot, Mix-and-Read Peptide-MHC Tetramers

Christian Leisner et al.

PLOS ONE (2008)